← Back to Search

Phase II: Lifestyle treatment for Obesity

N/A
Waitlist Available
Led By Elizabeth Parks, PhD
Research Sponsored by University of Missouri-Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day

Summary

This trial studies if losing weight and exercising can help people with fatty liver disease improve their liver health. Participants will either follow a special lifestyle program or receive usual health advice.

Eligible Conditions
  • Obesity
  • Non-alcoholic Fatty Liver Disease
  • Fatty Liver Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Liver mitochondrial gene expression
Secondary study objectives
Histology to determine the amount of fibrosis in the liver
Liver mitochondrial fat oxidation

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Phase II: Lifestyle treatmentExperimental Treatment1 Intervention
Subjects will undergo lifestyle modification to cause weight loss and improved fitness
Group II: Phase I: Observational studiesExperimental Treatment1 Intervention
Patients are eligible who are undergoing either bariatric surgery or a liver biopsy for the diagnosis of nonalcoholic fatty liver disease
Group III: Phase II: Control treatmentPlacebo Group1 Intervention
Subjects will be given dietary advice and a stretching program.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Phase II: Lifestyle treatment
2017
N/A
~340

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor
379 Previous Clinical Trials
628,158 Total Patients Enrolled
22 Trials studying Obesity
1,902 Patients Enrolled for Obesity
Elizabeth Parks, PhD4.58 ReviewsPrincipal Investigator - University of Missouri-Columbia
University of Missouri-Columbia
1 Previous Clinical Trials
5Patient Review
I found Elizabeth to be both caring and professional. I would wholeheartedly recommend her to others seeking out a PA.
Jamal Ibdah, MDPrincipal InvestigatorUniversity of Missouri-Columbia
~41 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top